Did you know…individual motors in each finger are positioned to optimise weight distribution – making the hand feel lighter and more comfortable.
Bebionic Photo
Posted in cyborgs, transhumanism
Posted in cyborgs, transhumanism
A new story by Scientific American on transhumanism: http://blogs.scientificamerican.com/cross-check/turned-off-b…resident/#
Transhumanist candidate Zoltan Istvan urges spending less on war and more on the scientific quest to defeat death.
Posted in government, robotics/AI, science, transhumanism | 1 Comment on I stopped by the NYC office today and chatted with veteran science writer John Horgan live on their Facebook page about transhumanism and my campaign
This has been a top trending video on SF Gate (the San Francisco Chronicle’s main website) for a few days now: http://video.sfgate.com/Zoltan-Istvan-Transhumanist-Party-Pr…e-31214223 The story is here and was also shared by Drudge Report: http://www.sfchronicle.com/opinion/openforum/article/Chip-en…694149.php
Biohacker says the U.S. Needs a Science Party Source: SFGate.com
Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.
“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”
As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.
With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.
The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.
Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.
“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
About RegenerAge SAPI de CV
RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.
My new story for The Daily Dot. Also, cool future tech to help the nonreligious get the message out:
Of the thousands of protesters at the Republican and Democratic conventions, one of the most noticeable groups were the born-again Christians. But this year—perhaps for the first time at national conventions—they were met with resistance from organized atheist and transhumanist protesters clashing against them.
With approximately a dozen atheists and transhumanists, my group of supporters engaged the Christians and campaigned in front of them. Sometimes wearing Transhumanist Party t-shirts and holding posters, we argued with them, blocked press from getting good pictures of them, and generally promoted to the public the power of reason over faith.
Other protesters, often fans of Bernie Sanders, joined our cause and helped protest against them. One of my favorites was an LGBT supporter holding up a sign with a penis drawing on it and the words “I love sinning” emblazoned just below it.
My new OpEd article for the San Francisco Chronicle on chip implants and transhumanism: http://www.sfchronicle.com/opinion/openforum/article/Chip-en…694149.php They also did a 2-minute video of my presidential campaign: http://bit.ly/2aERJxc
The implant can do all sorts of things, like unlock my electronic house door, act as my password on my computer, and even send a text message when people with the right phone and app come near me. Keys, credit cards, ID cards, medical records and passwords — these are all things that can be replaced by a tiny chip in the hand. If having technology in your bodies sounds wacky, consider the millions of people around the world who have artificial hips or dentures, or deaf people who use cochlear implants to hear sounds. […] former Vice President Dick Cheney famously asked to have the Wi-Fi on his heart valve turned off, just in case terrorists tried to hack it. A company in Sylmar (Los Angeles County) called Second Sight already has FDA approval for bionic eyes.
A new story with lots of transhumanism in it:
Zoltan Istvan is in the running for President of the United States. You may not have heard of him, but if elected, he hopes to put an end to death. All of it. (Yes, seriously).
There are people right now walking around with artificial hearts – something that many people believed would not happen for another decade (or even longer). There are quadriplegics no longer bound to a wheelchair, but walk with exoskeleton technology. There are hundreds of thousands of people with brain implants that help them with various ailments. In short, recent technological breakthroughs like these open up the possibility for humans to enhance themselves and their health—and perhaps to even become immortal (someday).
As you can imagine, such radical developments demand strong, intelligent and science-focused political leadership. That is why Zoltan Istvan, of the Transhumanist Party, says that he is running for U.S. President this year, as the #ScienceCandidate.